<?xml version="1.0" encoding="UTF-8"?>
<p id="JVEv5-para-0120">Engineering cells to produce antiviral proteins (AVPs) is another strategy that looks promising 
 <xref rid="JVEv5-bib-0027" ref-type="bibr">[27]</xref>. The AVPs may be secreted and typically act by preventing HIV-1 cellular infection by HIV-1. Examples include antibody-encoding sequences, which importantly do not need to be expressed from non-hematopoietic cells to provide HIV-1 resistance.
</p>
